Kodiak Sciences Inc (NASDAQ: KOD)
$3.01
-0.2350 ( -7.25% ) 386.4K
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.
Market Data
Open
$3.01
Previous close
$3.24
Volume
386.4K
Market cap
$158.13M
Day range
$2.91 - $3.25
52 week range
$1.37 - $7.77
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Jul 02, 2024 |
| 4 | Insider transactions | 1 | Jul 01, 2024 |
| 4 | Insider transactions | 1 | Jul 01, 2024 |
| 4 | Insider transactions | 1 | Jul 01, 2024 |
| 4 | Insider transactions | 1 | Jul 01, 2024 |
| 4 | Insider transactions | 1 | Jul 01, 2024 |
| 4 | Insider transactions | 1 | Jun 18, 2024 |
| 4 | Insider transactions | 1 | Jun 13, 2024 |
| 8-k | 8K-related | 13 | Jun 06, 2024 |
| 8-k | 8K-related | 12 | May 15, 2024 |